Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05258357 · ClinicalTrials.gov registry record · NA

Landmark vs. Ultrasound-Assisted Bone Marrow Biopsy Procedure Study

A NA study of Bone Marrow Biopsy Procedure, sponsored by Medical College of Wisconsin.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05258357: Active NA study of Bone Marrow Biopsy Procedure, sponsored by Medical College of Wisconsin.

NCT05258357 is a NA study of Bone Marrow Biopsy Procedure that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05258357, a NA study of Bone Marrow Biopsy Procedure, is active but no longer recruiting, sponsored by Medical College of Wisconsin.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Bone marrow biopsies are routinely performed by the Medicine Bedside Procedure Team service at Froedtert Hospital. Typical indications for inpatient bone marrow biopsies include evaluations for cytopenia, leukemia, lymphoma, myelodysplastic syndrome, or plasma cell dyscrasia. The bone marrow is sampled from the posterior iliac crest, ideally by drilling into the posterior superior iliac spine (PSIS). The Arrow® OnControl® Powered Bone Access System is utilized for this process. Most frequently, the location of the PSIS is estimated by using palpation of landmarks, such as the lateral iliac crests, spinous processes, sacrum, and the PSIS itself. Additionally, when using lidocaine to anesthetize the site, the needle is maneuvered to locate the most superficial portion of the PSIS, confirming the optimal drill anchor site. The correct direction/angle of the drill is estimated based on the orientation of the patient, typically directing it perpendicular to the coronal plane. Palpating landmarks to identify the posterior superior iliac spine is often difficult due to patient body habitus. Ultrasonography allows for accurate identification of the PSIS. It allows the clinician to pinpoint the best entry point in the skin and optimal drill angle to drive the needle perpendicular to the coronal plane. Furthermore, it allows the clinician to measure the distance from the skin to the PSIS, ensuring the drill bit is anchored onto the correct site. The benefits of an ultrasound approach have not been well documented. Therefore, this study will seek to provide evidence of benefits, or lack thereof, in using ultrasound for bone marrow biopsies. This will be achieved using a two-arm, open-label, randomized study design which will compare patient outcomes, as measured by pain assessment, bone marrow biopsy procedure metrics, and bone marrow biopsy sample quality, between subjects that have undergone the procedure using either the control landmark palpation method or ultrasound-ass

Primary Outcome

The proportion of adequate, suboptimal, and inadequate bone marrow biopsy samples, as measured by the overall length of evaluable marrow space using hematoxylin and eosin (H\&E) stained slides, will be compared between the landmark and ultrasound-assisted cohorts. Cores containing ≥1.5 cm of evaluable marrow space will be considered adequate, 0.5-1.5 cm suboptimal, and \<0.5 cm inadequate

Interventions

  • DEVICE Ultrasound-assisted bone marrow biopsy
  • PROCEDURE Landmark palpation bone marrow biopsy

Study Locations (1)

Wisconsin

  • Froedtert Hospital - Milwaukee

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-05-18
Est. Completion 2026-12-01
Phase NA
Medical College of Wisconsin

447 total trials

What the registry record for NCT05258357 still lists

NCT05258357 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Bone Marrow Biopsy Procedure appearing as the primary indexed condition, and to 2 interventions - of which Ultrasound-assisted bone marrow biopsy is the first listed.

NCT05258357 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05258357 about?

NCT05258357 is a clinical study titled "Landmark vs. Ultrasound-Assisted Bone Marrow Biopsy Procedure Study". Bone marrow biopsies are routinely performed by the Medicine Bedside Procedure Team service at Froedtert Hospital. Typical indications for inpatient bone marrow biopsies include evaluations for cytopenia, leukemia, lymphoma, myelodysplastic syndrome, or plasma cell dyscrasia. The bone marrow is samp...

What is the current status of trial NCT05258357?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-05-18. Estimated completion is 2026-12-01.

What conditions does trial NCT05258357 study?

This clinical trial studies the following conditions: Bone Marrow Biopsy Procedure.

What interventions are being tested in trial NCT05258357?

The interventions under investigation include: Ultrasound-assisted bone marrow biopsy (DEVICE), Landmark palpation bone marrow biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT05258357?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05258357 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT05258357's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05258357, the US trial registry maintained by the National Library of Medicine. NCT05258357 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.